nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—kidney cancer	0.303	1	CbGaD
Acebutolol—ABCB1—Temsirolimus—kidney cancer	0.068	0.143	CbGbCtD
Acebutolol—CYP2D6—Temsirolimus—kidney cancer	0.0641	0.135	CbGbCtD
Acebutolol—ABCB1—Pazopanib—kidney cancer	0.0357	0.0753	CbGbCtD
Acebutolol—CYP2D6—Pazopanib—kidney cancer	0.0336	0.071	CbGbCtD
Acebutolol—ABCB1—Dactinomycin—kidney cancer	0.0327	0.0689	CbGbCtD
Acebutolol—ABCB1—Gemcitabine—kidney cancer	0.0258	0.0545	CbGbCtD
Acebutolol—ABCB1—Erlotinib—kidney cancer	0.0255	0.0538	CbGbCtD
Acebutolol—CYP2D6—Erlotinib—kidney cancer	0.024	0.0507	CbGbCtD
Acebutolol—ABCB1—Paclitaxel—kidney cancer	0.0233	0.0492	CbGbCtD
Acebutolol—ABCB1—Sorafenib—kidney cancer	0.0207	0.0437	CbGbCtD
Acebutolol—ABCB1—Vinblastine—kidney cancer	0.0205	0.0432	CbGbCtD
Acebutolol—ABCB1—Vincristine—kidney cancer	0.0201	0.0424	CbGbCtD
Acebutolol—CYP2D6—Sorafenib—kidney cancer	0.0195	0.0412	CbGbCtD
Acebutolol—CYP2D6—Vinblastine—kidney cancer	0.0193	0.0407	CbGbCtD
Acebutolol—ABCB1—Sunitinib—kidney cancer	0.0168	0.0354	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—kidney cancer	0.0126	0.0265	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—kidney cancer	0.0118	0.025	CbGbCtD
Acebutolol—Vomiting—Everolimus—kidney cancer	0.000187	0.000841	CcSEcCtD
Acebutolol—Paraesthesia—Vincristine—kidney cancer	0.000187	0.000839	CcSEcCtD
Acebutolol—Rash—Everolimus—kidney cancer	0.000186	0.000834	CcSEcCtD
Acebutolol—Dermatitis—Everolimus—kidney cancer	0.000186	0.000833	CcSEcCtD
Acebutolol—Headache—Vinblastine—kidney cancer	0.000185	0.000832	CcSEcCtD
Acebutolol—Headache—Everolimus—kidney cancer	0.000185	0.000829	CcSEcCtD
Acebutolol—Hypotension—Gemcitabine—kidney cancer	0.000185	0.000829	CcSEcCtD
Acebutolol—Abdominal pain—Dactinomycin—kidney cancer	0.000184	0.000827	CcSEcCtD
Acebutolol—Body temperature increased—Dactinomycin—kidney cancer	0.000184	0.000827	CcSEcCtD
Acebutolol—Visual impairment—Capecitabine—kidney cancer	0.000184	0.000826	CcSEcCtD
Acebutolol—Asthenia—Sorafenib—kidney cancer	0.000184	0.000824	CcSEcCtD
Acebutolol—Malaise—Paclitaxel—kidney cancer	0.000183	0.00082	CcSEcCtD
Acebutolol—Cardiac failure—Doxorubicin—kidney cancer	0.000182	0.000819	CcSEcCtD
Acebutolol—Vertigo—Paclitaxel—kidney cancer	0.000182	0.000817	CcSEcCtD
Acebutolol—Syncope—Paclitaxel—kidney cancer	0.000182	0.000816	CcSEcCtD
Acebutolol—Lethargy—Doxorubicin—kidney cancer	0.000182	0.000815	CcSEcCtD
Acebutolol—Decreased appetite—Vincristine—kidney cancer	0.000181	0.000813	CcSEcCtD
Acebutolol—Pruritus—Sorafenib—kidney cancer	0.000181	0.000813	CcSEcCtD
Acebutolol—Vomiting—Erlotinib—kidney cancer	0.000181	0.000812	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00018	0.000808	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Vincristine—kidney cancer	0.00018	0.000807	CcSEcCtD
Acebutolol—Fatigue—Vincristine—kidney cancer	0.00018	0.000806	CcSEcCtD
Acebutolol—Rash—Erlotinib—kidney cancer	0.000179	0.000805	CcSEcCtD
Acebutolol—Dermatitis—Erlotinib—kidney cancer	0.000179	0.000804	CcSEcCtD
Acebutolol—Palpitations—Paclitaxel—kidney cancer	0.000179	0.000804	CcSEcCtD
Acebutolol—Insomnia—Gemcitabine—kidney cancer	0.000179	0.000802	CcSEcCtD
Acebutolol—Headache—Erlotinib—kidney cancer	0.000178	0.0008	CcSEcCtD
Acebutolol—Tinnitus—Capecitabine—kidney cancer	0.000178	0.0008	CcSEcCtD
Acebutolol—Loss of consciousness—Paclitaxel—kidney cancer	0.000178	0.0008	CcSEcCtD
Acebutolol—Pain—Vincristine—kidney cancer	0.000178	0.000799	CcSEcCtD
Acebutolol—Constipation—Vincristine—kidney cancer	0.000178	0.000799	CcSEcCtD
Acebutolol—Pain in extremity—Doxorubicin—kidney cancer	0.000178	0.000799	CcSEcCtD
Acebutolol—Paraesthesia—Gemcitabine—kidney cancer	0.000177	0.000796	CcSEcCtD
Acebutolol—Flushing—Capecitabine—kidney cancer	0.000177	0.000796	CcSEcCtD
Acebutolol—Cough—Paclitaxel—kidney cancer	0.000177	0.000794	CcSEcCtD
Acebutolol—Asthenia—Sunitinib—kidney cancer	0.000177	0.000793	CcSEcCtD
Acebutolol—Dyspnoea—Gemcitabine—kidney cancer	0.000176	0.000791	CcSEcCtD
Acebutolol—Nausea—Vinblastine—kidney cancer	0.000176	0.000789	CcSEcCtD
Acebutolol—Somnolence—Gemcitabine—kidney cancer	0.000176	0.000788	CcSEcCtD
Acebutolol—Affect lability—Doxorubicin—kidney cancer	0.000175	0.000787	CcSEcCtD
Acebutolol—Nausea—Everolimus—kidney cancer	0.000175	0.000786	CcSEcCtD
Acebutolol—Diarrhoea—Sorafenib—kidney cancer	0.000175	0.000786	CcSEcCtD
Acebutolol—Pruritus—Sunitinib—kidney cancer	0.000174	0.000782	CcSEcCtD
Acebutolol—Angiopathy—Capecitabine—kidney cancer	0.000173	0.000778	CcSEcCtD
Acebutolol—Chest pain—Paclitaxel—kidney cancer	0.000173	0.000774	CcSEcCtD
Acebutolol—Myalgia—Paclitaxel—kidney cancer	0.000173	0.000774	CcSEcCtD
Acebutolol—Arthralgia—Paclitaxel—kidney cancer	0.000173	0.000774	CcSEcCtD
Acebutolol—Mediastinal disorder—Capecitabine—kidney cancer	0.000172	0.000773	CcSEcCtD
Acebutolol—Anxiety—Paclitaxel—kidney cancer	0.000172	0.000772	CcSEcCtD
Acebutolol—Decreased appetite—Gemcitabine—kidney cancer	0.000172	0.000771	CcSEcCtD
Acebutolol—Chills—Capecitabine—kidney cancer	0.000171	0.000769	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000171	0.000769	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000171	0.000766	CcSEcCtD
Acebutolol—Discomfort—Paclitaxel—kidney cancer	0.000171	0.000765	CcSEcCtD
Acebutolol—Fatigue—Gemcitabine—kidney cancer	0.00017	0.000765	CcSEcCtD
Acebutolol—Gastrointestinal pain—Vincristine—kidney cancer	0.00017	0.000764	CcSEcCtD
Acebutolol—Dizziness—Sorafenib—kidney cancer	0.000169	0.00076	CcSEcCtD
Acebutolol—Pain—Gemcitabine—kidney cancer	0.000169	0.000758	CcSEcCtD
Acebutolol—Constipation—Gemcitabine—kidney cancer	0.000169	0.000758	CcSEcCtD
Acebutolol—Nausea—Erlotinib—kidney cancer	0.000169	0.000758	CcSEcCtD
Acebutolol—Alopecia—Capecitabine—kidney cancer	0.000169	0.000758	CcSEcCtD
Acebutolol—Mood swings—Doxorubicin—kidney cancer	0.000169	0.000757	CcSEcCtD
Acebutolol—Diarrhoea—Sunitinib—kidney cancer	0.000168	0.000756	CcSEcCtD
Acebutolol—Asthenia—Dactinomycin—kidney cancer	0.000167	0.000751	CcSEcCtD
Acebutolol—Confusional state—Paclitaxel—kidney cancer	0.000167	0.000749	CcSEcCtD
Acebutolol—Oedema—Paclitaxel—kidney cancer	0.000165	0.000742	CcSEcCtD
Acebutolol—Abdominal pain—Vincristine—kidney cancer	0.000165	0.000739	CcSEcCtD
Acebutolol—Body temperature increased—Vincristine—kidney cancer	0.000165	0.000739	CcSEcCtD
Acebutolol—Flatulence—Capecitabine—kidney cancer	0.000164	0.000736	CcSEcCtD
Acebutolol—Dizziness—Sunitinib—kidney cancer	0.000163	0.000731	CcSEcCtD
Acebutolol—Feeling abnormal—Gemcitabine—kidney cancer	0.000163	0.000731	CcSEcCtD
Acebutolol—Shock—Paclitaxel—kidney cancer	0.000163	0.00073	CcSEcCtD
Acebutolol—Vomiting—Sorafenib—kidney cancer	0.000163	0.00073	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000163	0.00073	CcSEcCtD
Acebutolol—Nervous system disorder—Paclitaxel—kidney cancer	0.000162	0.000728	CcSEcCtD
Acebutolol—Rash—Sorafenib—kidney cancer	0.000161	0.000724	CcSEcCtD
Acebutolol—Dermatitis—Sorafenib—kidney cancer	0.000161	0.000724	CcSEcCtD
Acebutolol—Back pain—Capecitabine—kidney cancer	0.000161	0.000722	CcSEcCtD
Acebutolol—Skin disorder—Paclitaxel—kidney cancer	0.000161	0.000721	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00016	0.00072	CcSEcCtD
Acebutolol—Headache—Sorafenib—kidney cancer	0.00016	0.00072	CcSEcCtD
Acebutolol—Hyperhidrosis—Paclitaxel—kidney cancer	0.00016	0.000718	CcSEcCtD
Acebutolol—Diarrhoea—Dactinomycin—kidney cancer	0.00016	0.000716	CcSEcCtD
Acebutolol—Anorexia—Paclitaxel—kidney cancer	0.000158	0.000708	CcSEcCtD
Acebutolol—Vision blurred—Capecitabine—kidney cancer	0.000157	0.000704	CcSEcCtD
Acebutolol—Vomiting—Sunitinib—kidney cancer	0.000157	0.000703	CcSEcCtD
Acebutolol—Body temperature increased—Gemcitabine—kidney cancer	0.000156	0.000701	CcSEcCtD
Acebutolol—Rash—Sunitinib—kidney cancer	0.000155	0.000697	CcSEcCtD
Acebutolol—Dermatitis—Sunitinib—kidney cancer	0.000155	0.000696	CcSEcCtD
Acebutolol—Hypotension—Paclitaxel—kidney cancer	0.000155	0.000694	CcSEcCtD
Acebutolol—Ill-defined disorder—Capecitabine—kidney cancer	0.000154	0.000693	CcSEcCtD
Acebutolol—Headache—Sunitinib—kidney cancer	0.000154	0.000692	CcSEcCtD
Acebutolol—Nausea—Sorafenib—kidney cancer	0.000152	0.000682	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000151	0.000676	CcSEcCtD
Acebutolol—Malaise—Capecitabine—kidney cancer	0.00015	0.000673	CcSEcCtD
Acebutolol—Insomnia—Paclitaxel—kidney cancer	0.00015	0.000672	CcSEcCtD
Acebutolol—Vertigo—Capecitabine—kidney cancer	0.000149	0.000671	CcSEcCtD
Acebutolol—Asthenia—Vincristine—kidney cancer	0.000149	0.000671	CcSEcCtD
Acebutolol—Syncope—Capecitabine—kidney cancer	0.000149	0.000669	CcSEcCtD
Acebutolol—Paraesthesia—Paclitaxel—kidney cancer	0.000149	0.000667	CcSEcCtD
Acebutolol—Vomiting—Dactinomycin—kidney cancer	0.000148	0.000665	CcSEcCtD
Acebutolol—Atenolol—ABCB1—kidney cancer	0.000148	0.343	CrCbGaD
Acebutolol—Dyspnoea—Paclitaxel—kidney cancer	0.000147	0.000662	CcSEcCtD
Acebutolol—Somnolence—Paclitaxel—kidney cancer	0.000147	0.00066	CcSEcCtD
Acebutolol—Palpitations—Capecitabine—kidney cancer	0.000147	0.00066	CcSEcCtD
Acebutolol—Rash—Dactinomycin—kidney cancer	0.000147	0.00066	CcSEcCtD
Acebutolol—Nausea—Sunitinib—kidney cancer	0.000146	0.000656	CcSEcCtD
Acebutolol—Loss of consciousness—Capecitabine—kidney cancer	0.000146	0.000656	CcSEcCtD
Acebutolol—Dyspepsia—Paclitaxel—kidney cancer	0.000146	0.000654	CcSEcCtD
Acebutolol—Cough—Capecitabine—kidney cancer	0.000145	0.000651	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—kidney cancer	0.000144	0.000646	CcSEcCtD
Acebutolol—Decreased appetite—Paclitaxel—kidney cancer	0.000144	0.000645	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000143	0.000641	CcSEcCtD
Acebutolol—Fatigue—Paclitaxel—kidney cancer	0.000143	0.00064	CcSEcCtD
Acebutolol—Diarrhoea—Vincristine—kidney cancer	0.000143	0.00064	CcSEcCtD
Acebutolol—Asthenia—Gemcitabine—kidney cancer	0.000142	0.000636	CcSEcCtD
Acebutolol—Arthralgia—Capecitabine—kidney cancer	0.000142	0.000636	CcSEcCtD
Acebutolol—Chest pain—Capecitabine—kidney cancer	0.000142	0.000636	CcSEcCtD
Acebutolol—Myalgia—Capecitabine—kidney cancer	0.000142	0.000636	CcSEcCtD
Acebutolol—Constipation—Paclitaxel—kidney cancer	0.000141	0.000635	CcSEcCtD
Acebutolol—Pain—Paclitaxel—kidney cancer	0.000141	0.000635	CcSEcCtD
Acebutolol—Anxiety—Capecitabine—kidney cancer	0.000141	0.000633	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000141	0.000631	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—kidney cancer	0.00014	0.000629	CcSEcCtD
Acebutolol—Discomfort—Capecitabine—kidney cancer	0.00014	0.000628	CcSEcCtD
Acebutolol—Pruritus—Gemcitabine—kidney cancer	0.00014	0.000627	CcSEcCtD
Acebutolol—Nausea—Dactinomycin—kidney cancer	0.000138	0.000621	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—kidney cancer	0.000138	0.000619	CcSEcCtD
Acebutolol—Dizziness—Vincristine—kidney cancer	0.000138	0.000618	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—kidney cancer	0.000137	0.000616	CcSEcCtD
Acebutolol—Confusional state—Capecitabine—kidney cancer	0.000137	0.000614	CcSEcCtD
Acebutolol—Feeling abnormal—Paclitaxel—kidney cancer	0.000136	0.000612	CcSEcCtD
Acebutolol—Oedema—Capecitabine—kidney cancer	0.000136	0.000609	CcSEcCtD
Acebutolol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000135	0.000607	CcSEcCtD
Acebutolol—Diarrhoea—Gemcitabine—kidney cancer	0.000135	0.000607	CcSEcCtD
Acebutolol—Shock—Capecitabine—kidney cancer	0.000134	0.000599	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—kidney cancer	0.000133	0.000599	CcSEcCtD
Acebutolol—Nervous system disorder—Capecitabine—kidney cancer	0.000133	0.000598	CcSEcCtD
Acebutolol—Vomiting—Vincristine—kidney cancer	0.000132	0.000594	CcSEcCtD
Acebutolol—Skin disorder—Capecitabine—kidney cancer	0.000132	0.000592	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—kidney cancer	0.000132	0.00059	CcSEcCtD
Acebutolol—Urticaria—Paclitaxel—kidney cancer	0.000131	0.00059	CcSEcCtD
Acebutolol—Rash—Vincristine—kidney cancer	0.000131	0.000589	CcSEcCtD
Acebutolol—Hyperhidrosis—Capecitabine—kidney cancer	0.000131	0.000589	CcSEcCtD
Acebutolol—Dermatitis—Vincristine—kidney cancer	0.000131	0.000589	CcSEcCtD
Acebutolol—Abdominal pain—Paclitaxel—kidney cancer	0.000131	0.000587	CcSEcCtD
Acebutolol—Body temperature increased—Paclitaxel—kidney cancer	0.000131	0.000587	CcSEcCtD
Acebutolol—Headache—Vincristine—kidney cancer	0.00013	0.000586	CcSEcCtD
Acebutolol—Anorexia—Capecitabine—kidney cancer	0.000129	0.000581	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—kidney cancer	0.000128	0.000575	CcSEcCtD
Acebutolol—Hypotension—Capecitabine—kidney cancer	0.000127	0.000569	CcSEcCtD
Acebutolol—Vomiting—Gemcitabine—kidney cancer	0.000126	0.000564	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—kidney cancer	0.000125	0.000563	CcSEcCtD
Acebutolol—Rash—Gemcitabine—kidney cancer	0.000125	0.000559	CcSEcCtD
Acebutolol—Dermatitis—Gemcitabine—kidney cancer	0.000124	0.000559	CcSEcCtD
Acebutolol—Headache—Gemcitabine—kidney cancer	0.000124	0.000556	CcSEcCtD
Acebutolol—Nausea—Vincristine—kidney cancer	0.000124	0.000555	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000124	0.000555	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—kidney cancer	0.000123	0.000554	CcSEcCtD
Acebutolol—Insomnia—Capecitabine—kidney cancer	0.000123	0.000551	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—kidney cancer	0.000123	0.00055	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—kidney cancer	0.000122	0.000549	CcSEcCtD
Acebutolol—Paraesthesia—Capecitabine—kidney cancer	0.000122	0.000547	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—kidney cancer	0.000121	0.000543	CcSEcCtD
Acebutolol—Dyspnoea—Capecitabine—kidney cancer	0.000121	0.000543	CcSEcCtD
Acebutolol—Dyspepsia—Capecitabine—kidney cancer	0.00012	0.000536	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—kidney cancer	0.000119	0.000533	CcSEcCtD
Acebutolol—Asthenia—Paclitaxel—kidney cancer	0.000119	0.000533	CcSEcCtD
Acebutolol—Decreased appetite—Capecitabine—kidney cancer	0.000118	0.00053	CcSEcCtD
Acebutolol—Nausea—Gemcitabine—kidney cancer	0.000117	0.000527	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000117	0.000526	CcSEcCtD
Acebutolol—Fatigue—Capecitabine—kidney cancer	0.000117	0.000525	CcSEcCtD
Acebutolol—Pruritus—Paclitaxel—kidney cancer	0.000117	0.000525	CcSEcCtD
Acebutolol—Constipation—Capecitabine—kidney cancer	0.000116	0.000521	CcSEcCtD
Acebutolol—Pain—Capecitabine—kidney cancer	0.000116	0.000521	CcSEcCtD
Acebutolol—Metoprolol—ABCB1—kidney cancer	0.000115	0.268	CrCbGaD
Acebutolol—Tinnitus—Doxorubicin—kidney cancer	0.000115	0.000515	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—kidney cancer	0.000114	0.000513	CcSEcCtD
Acebutolol—Diarrhoea—Paclitaxel—kidney cancer	0.000113	0.000508	CcSEcCtD
Acebutolol—Feeling abnormal—Capecitabine—kidney cancer	0.000112	0.000502	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—kidney cancer	0.000112	0.000502	CcSEcCtD
Acebutolol—Gastrointestinal pain—Capecitabine—kidney cancer	0.000111	0.000498	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—kidney cancer	0.000111	0.000498	CcSEcCtD
Acebutolol—Chills—Doxorubicin—kidney cancer	0.000111	0.000496	CcSEcCtD
Acebutolol—Propranolol—CYP1A1—kidney cancer	0.00011	0.254	CrCbGaD
Acebutolol—Dizziness—Paclitaxel—kidney cancer	0.000109	0.000491	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—kidney cancer	0.000109	0.000488	CcSEcCtD
Acebutolol—Urticaria—Capecitabine—kidney cancer	0.000108	0.000484	CcSEcCtD
Acebutolol—Abdominal pain—Capecitabine—kidney cancer	0.000107	0.000482	CcSEcCtD
Acebutolol—Body temperature increased—Capecitabine—kidney cancer	0.000107	0.000482	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—kidney cancer	0.000106	0.000474	CcSEcCtD
Acebutolol—Vomiting—Paclitaxel—kidney cancer	0.000105	0.000472	CcSEcCtD
Acebutolol—Rash—Paclitaxel—kidney cancer	0.000104	0.000468	CcSEcCtD
Acebutolol—Dermatitis—Paclitaxel—kidney cancer	0.000104	0.000468	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—kidney cancer	0.000104	0.000465	CcSEcCtD
Acebutolol—Headache—Paclitaxel—kidney cancer	0.000104	0.000465	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—kidney cancer	0.000101	0.000454	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—kidney cancer	9.95e-05	0.000447	CcSEcCtD
Acebutolol—Nausea—Paclitaxel—kidney cancer	9.83e-05	0.000441	CcSEcCtD
Acebutolol—Asthenia—Capecitabine—kidney cancer	9.74e-05	0.000437	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—kidney cancer	9.67e-05	0.000434	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—kidney cancer	9.63e-05	0.000432	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—kidney cancer	9.62e-05	0.000432	CcSEcCtD
Acebutolol—Pruritus—Capecitabine—kidney cancer	9.61e-05	0.000431	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—kidney cancer	9.48e-05	0.000425	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—kidney cancer	9.42e-05	0.000423	CcSEcCtD
Acebutolol—Cough—Doxorubicin—kidney cancer	9.36e-05	0.00042	CcSEcCtD
Acebutolol—Diarrhoea—Capecitabine—kidney cancer	9.29e-05	0.000417	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—kidney cancer	9.13e-05	0.00041	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—kidney cancer	9.13e-05	0.00041	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—kidney cancer	9.13e-05	0.00041	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—kidney cancer	9.1e-05	0.000408	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.07e-05	0.000407	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—kidney cancer	9.02e-05	0.000405	CcSEcCtD
Acebutolol—Dizziness—Capecitabine—kidney cancer	8.98e-05	0.000403	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—kidney cancer	8.82e-05	0.000396	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—kidney cancer	8.75e-05	0.000393	CcSEcCtD
Acebutolol—Vomiting—Capecitabine—kidney cancer	8.63e-05	0.000387	CcSEcCtD
Acebutolol—Shock—Doxorubicin—kidney cancer	8.61e-05	0.000386	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—kidney cancer	8.58e-05	0.000385	CcSEcCtD
Acebutolol—Rash—Capecitabine—kidney cancer	8.56e-05	0.000384	CcSEcCtD
Acebutolol—Dermatitis—Capecitabine—kidney cancer	8.55e-05	0.000384	CcSEcCtD
Acebutolol—Headache—Capecitabine—kidney cancer	8.5e-05	0.000382	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—kidney cancer	8.5e-05	0.000381	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—kidney cancer	8.46e-05	0.00038	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—kidney cancer	8.34e-05	0.000374	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—kidney cancer	8.18e-05	0.000367	CcSEcCtD
Acebutolol—Nausea—Capecitabine—kidney cancer	8.06e-05	0.000362	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.97e-05	0.000358	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—kidney cancer	7.92e-05	0.000355	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—kidney cancer	7.86e-05	0.000353	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—kidney cancer	7.8e-05	0.00035	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—kidney cancer	7.78e-05	0.000349	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—kidney cancer	7.7e-05	0.000346	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—kidney cancer	7.61e-05	0.000341	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.56e-05	0.000339	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—kidney cancer	7.54e-05	0.000339	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—kidney cancer	7.48e-05	0.000336	CcSEcCtD
Acebutolol—Pain—Doxorubicin—kidney cancer	7.48e-05	0.000336	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—kidney cancer	7.21e-05	0.000324	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—kidney cancer	7.16e-05	0.000321	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—kidney cancer	6.95e-05	0.000312	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—kidney cancer	6.92e-05	0.00031	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—kidney cancer	6.92e-05	0.00031	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—kidney cancer	6.28e-05	0.000282	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—kidney cancer	6.19e-05	0.000278	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—kidney cancer	5.99e-05	0.000269	CcSEcCtD
Acebutolol—Propranolol—ABCB1—kidney cancer	5.83e-05	0.135	CrCbGaD
Acebutolol—Dizziness—Doxorubicin—kidney cancer	5.79e-05	0.00026	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—kidney cancer	5.56e-05	0.00025	CcSEcCtD
Acebutolol—Rash—Doxorubicin—kidney cancer	5.52e-05	0.000248	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—kidney cancer	5.51e-05	0.000247	CcSEcCtD
Acebutolol—Headache—Doxorubicin—kidney cancer	5.48e-05	0.000246	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—kidney cancer	5.2e-05	0.000233	CcSEcCtD
